Results & Financial lifeHealthcare - Pharma - Biotech
Strong organic growth of 7.1% in Q1 2026-2027
12/11/2026 18:00
AMFImmediate publication
Caissargues, November 12, 2026 – Groupe Bastide, a leading European provider of home healthcare services and homecare, has published its revenue for first-quarter 2026-2027, ending September 30, 2026.
Strong organic growth of 7.1% in
Q1 2026-2027
- Home Healthcare Services: growth of 7.8%, driven by the Respiratory care and Diabetes businesses;
- Homecare: growth of 6.2%, supported by strong momentum in stores and healthcare institutions business.
Caissargues, November 12, 2026 – Groupe Bastide, a leading European provider of home healthcare services and homecare, has published its revenue for first-quarter 2026-2027, ending September 30, 2026.
- Revenue restated for discontinued operations (IFRS 5): Experf sold in 2025-2026
Solid organic growth of 7.1% in Q1 2026-2027
Groupe Bastide confirms its positive growth momentum in Q1, with revenue of €124.3 million, representing organic growth1 7,1% (+7.5% on a reported basis).
Home Healthcare Services (Respiratory care, Nutrition-Perfusion-Diabetes-Stomatherapy) maintained strong performance, at 8.4% (+7.8% organic growth).
The positive momentum in the Homecare business also continued, with organic growth of 6.2% over the quarter, driven by strong performance in both stores and healthcare institutions business.
Répartition du chiffre d’affaires par métier
Homecare: revenue amounted to €52.0 million, up 6.2%:
- In the healthcare institutions business, revenue stood at €23.4 million, up 6.7%, driven by strong momentum in higher-margin rental activities, which remain a key focus for Groupe Bastide, as well as the contribution from one-off contracts.
- In Stores/online, revenue stood at €28.6 million, up 5.8%, driven in particular by growth in wheelchair sales following the implementation of the VPH2 reform.
1 Organic growth calculated at constant exchange rates and based on a comparable scope of consolidation: 202 5-2026 figures restated for the contribution of assets sold within the last 12 months and assets classified as held for sale. 2 Véhicules pour Personnes Handicapées (Vehicles for People with Disabilities)
In € million 2025-2026 reported
2025-2026 restated*
2026-2027 reported Change
Q1 revenue 126.3 115.6 124.3 +7.5%
Reuters BATD.PA, - Bloomberg BLC: FP, ISIN FR0000035370, Nombre de titres 7 348 419 2 The Respiratory care business maintained strong momentum, with revenue reaching €45.9 million, up 10.6% (+9.6% organic growth). Despite the impact of a 4% price reduction in the sleep apnoea segment effective 1 April 2026, organic growth in France reached 6.8%, driven by the structural growth of the market and market share gains. On a reported basis, growth stood at 8.2%, including the contribution of a small company acquired in the Lille region at the beginning of the first quarter. Internationally, Groupe Bastide continued to record very strong business momentum, with growth of nearly 20%, supported by excellent performances from Oxystore in Italy and Intus in the United Kingdom.